Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation.
about
Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.Population pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation.A simple dosing scheme for intravenous busulfan based on retrospective population pharmacokinetic analysis in korean patientsProspective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation.Busulfan in hematopoietic stem cell transplant setting.Granulocyte colony-stimulating factor (G-CSF) promotes spermatogenic regeneration from surviving spermatogonia after high-dose alkylating chemotherapy.Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?Influence of GST gene polymorphisms on busulfan pharmacokinetics in children.Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study.Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen.Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.Development of multiplex PCR method for the analysis of glutathione s-transferase polymorphism.
P2860
Q35486314-A4E625C1-FE0A-4C5E-8065-CAE200BDB4FCQ35596516-7691B80F-AD44-4B38-B3D3-47119EFE9580Q36166109-89E227F8-D938-4236-9E98-160E4907F16AQ36881201-2DADBD19-F802-493C-A187-C4215A02D4EAQ37554387-91867357-76A0-4E97-BA29-ED1E8F089F12Q37579159-37776E28-CDB1-4B0D-84D1-E958DCA53899Q39488956-191169C8-3A78-4817-9DB2-6311B71B2391Q43248045-053D8ED4-BC2A-4398-B252-5254C70BB591Q45936278-EACEE809-B794-47AF-9932-B5EE5312C5D2Q46244551-20EE4761-28B7-4B98-8337-CAA8DB32C051Q46847077-C810AC2B-8204-4422-9029-9D14B3CD1D43Q50924228-C304CA4B-76D7-405F-B43B-B016AB8FA6F8Q53399897-D2206035-6BC1-42C8-A8CF-190D27C057A9
P2860
Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Population pharmacokinetics of ...... tic stem cell transplantation.
@en
Population pharmacokinetics of ...... tic stem cell transplantation.
@nl
type
label
Population pharmacokinetics of ...... tic stem cell transplantation.
@en
Population pharmacokinetics of ...... tic stem cell transplantation.
@nl
prefLabel
Population pharmacokinetics of ...... tic stem cell transplantation.
@en
Population pharmacokinetics of ...... tic stem cell transplantation.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... tic stem cell transplantation.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705252
P407
P577
2006-02-01T00:00:00Z